Upgrade to SI Premium - Free Trial

Amgen (AMGN) PT Raised to $224 at Oppenheimer

February 2, 2018 6:54 AM
Oppenheimer raised its price target on Amgen (NASDAQ: AMGN) to $224.00 (from $205.00) while maintaining an Outperform rating.Analyst Leah Rush ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles